Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000850261-19-000018
Filing Date
2019-04-30
Accepted
2019-04-29 21:17:38
Documents
3
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a201810-kaproxy.htm 10-K/A 611623
2 EXHIBIT 31.3 a2018ex313.htm EX-31.3 8668
3 EXHIBIT 31.4 a2018ex314.htm EX-31.4 8601
  Complete submission text file 0000850261-19-000018.txt   629997
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36150 | Film No.: 19777992
SIC: 8731 Services-Commercial Physical & Biological Research